Fabros, Jullian Mae .

HRN: 26-87-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/29/2025
04/08/2025
IV
70mg
Q8h
AGE With Moderate Dehydration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: